Brainstorm Cell Therapeutics

$3.64
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.06 (1.68%) As of 1:11 PM EDT today
+$0.06 (1.68%) Today

Why Robinhood?

You can buy or sell BCLI and other stocks, options, ETFs, and crypto commission-free!

About BCLI

Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops and commercializes adult stem cell therapeutic products. It focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis and spinal cord injury. Read More The company was founded on September 22, 2000 and is headquartered in New York, NJ.

Employees
31
Headquarters
New York, New Jersey
Founded
2000
Market Cap
80.73M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
217.17K
High Today
$3.70
Low Today
$3.58
Open Price
$3.58
Volume
25.77K
52 Week High
$4.50
52 Week Low
$2.92

Collections

BCLI Earnings

-$0.32
-$0.21
-$0.09
$0.02
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.24 per share
Actual
-$0.23 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.